0
Views
64
CrossRef citations to date
0
Altmetric
Research Article

Transcriptional Down Regulation of the nov Proto-Oncogene in Fibroblasts Transformed by p60v-src

, , &
Pages 481-486 | Received 22 Aug 1995, Accepted 01 Nov 1995, Published online: 29 Mar 2023

REFERENCES

  • Adams, S. L., J. C. Alwine, B. de Crombrugghe, and I. Pastan. 1979. Use of recombinant plasmids to characterize collagen RNAs in normal and transformed chicken embryo fibroblasts. J. Biol. Chem. 254:4935–4938.
  • Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592–5595.
  • Apel, I., C.-L. Yu, T. Wang, C. Dobry, M. E. van Antwerp, R. Jove, and E. V. Prochownik. 1992. Regulation of the junB gene by v-src. Mol. Cell. Biol. 12:3356–3364.
  • August, A., and H. Hanafusa. Unpublished data.
  • Bédard, P.-A., D. Alcorta, D. L. Simmons, K.-C. Luk, and R. L. Erikson. 1987. Constitutive expression of a gene encoding a polypeptide homologous to biologically active platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 84:6715–6719.
  • Birchenall-Roberts, M. C., F. W. Ruscetti, J. Kasper, H.-D. Lee, R. Friedman, A. Geiser, M. B. Sporn, A. B. Roberts, and S.-J. Kim. 1990. Transcriptional regulation of the transforming growth factor β1 promoter by v-src gene products is mediated through the AP-1 complex. Mol. Cell. Biol. 10: 4978–4983.
  • Bradham, D. M., A. Igarashi, R. L. Potter, and G. R. Grotendorst. 1991. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1285–1294.
  • Calothy, G., D. Laugier, F. R. Cross, R. Jove, T. Hanafusa, and H. Hanafusa. 1987. The membrane-binding domain and myristylation of pp60v-src are not essential for stimulation of cell proliferation. J. Virol. 61:1678–1681.
  • Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′ untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670–1674.
  • Celano, P., C. Berchtold, and R. A. Casero, Jr. 1989. A simplification of the nuclear run-off transcription assay. BioTechniques 7:942–944.
  • Decker, C. J., and R. Parker. 1993. A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev. 7:1632–1643.
  • Dehbi, M., A. Mbiguino, M. Beauchemin, G. Chatelain, and P.-A. Bedard. 1992. Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src. Mol. Cell. Biol. 12:1490–1499.
  • Dutta, A., M. Y. Stoeckle, and H. Hanafusa. 1990. Serum and v-src increase the level of a CCAAT-binding factor required for transcription from a retroviral long terminal repeat. Genes Dev. 4:243–254.
  • Fagan, J. B., M. E. Sobel, K. M. Yamada, B. de Crombrugghe, and I. Pastan. 1981. Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J. Biol. Chem. 256:520–525.
  • Fiszman, M. Y., and P. Fuchs. 1975. Temperature-sensitive expression of differentiation in transformed myoblasts. Nature (London) 254:429–431.
  • Fukui, Y., and H. Hanafusa. 1989. Phosphatidylinositol kinase activity associates with viral p60src protein. Mol. Cell. Biol. 9:1651–1658.
  • Fujii, M. D., D. Shalloway, and I. M. Verma. 1989. Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos. Mol. Cell. Biol. 9:2493–2499.
  • Glenney, J. R., Jr., and L. Zokas. 1989. Novel tyrosine kinase substrates for Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108:2401–2408.
  • Golden, A., and J. S. Brugge. 1988. The src oncogene, p. 149–173. In E. R. Reddy, A. M. Skalka, and T. Curran (ed.), The oncogene handbook. Elsevier, Amsterdam.
  • Hanafusa, H.. 1969. Rapid transformation of cells by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 63:318–325.
  • Holtzer, H., J. Biehl, G. Yeoh, R. Meganathan, and A. Kaji. 1975. Effects of oncogenic virus on muscle differentiation. Proc. Natl. Acad. Sci. USA 72: 4051–4055.
  • Hunter, T., and J. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Bio-chem. 54:897–930.
  • Joliot, V., C. Martinerie, G. Dambrine, G. Plassiart, M. Brisac, J. Crochet, and B. Perbal. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Biol. 12:10–21.
  • Joseph, C. K., S. A. Qureshi, D. J. Wallace, and D. A. Foster. 1992. MARCKS protein is transcriptionally down-regulated in v-src-transformed BALB/c 3T3 cells. J. Biol. Chem. 267:1327–1330.
  • Jove, R., and H. Hanafusa. 1987. Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol. 3:31–56.
  • Kawamoto, S., and H. Hidaka. 1984. 1-(5-Isoquinolinesulfonyl)-2-meth-ylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem. Biophys. Res. Commun. 125:258–264.
  • Kozma, L. M., and M. J. Weber. 1990. Constitutive phosphorylation of the receptor for insulinlike growth factor 1 in cells transformed by the src oncogene. Mol. Cell. Biol. 10:3626–3634.
  • Kypta, R. M., Y. Goldberg, E. T. Ulug, and S. Courtneidge. 1990. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62:481–492.
  • Levy, J. B., H. Iba, and H. Hanafusa. 1986. Activation of the transforming potential of p60c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83:4228–4232.
  • Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967–971.
  • Martinerie, C.., V. Huff, I. Joubert, M. Badzioch, G. Saunders, L. Strong, and B. Perbal. 1994. Structural analysis of the human nov proto-oncogene and expression in Wilm’s tumors. Oncogene 9:2729–2732.
  • Martinerie, C.., E. Viegas-Pequignot, I. Guenard, B. Dutrillaux, V. C. Nguyen, A. Bernheim, and B. Perbal. 1992. Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene 7:2529–2534.
  • Mayer, B. J., R. Jove, J. F. Krane, F. Poirier, G. Calothy, and H. Hanafusa. 1986. Genetic lesions involved in temperature sensitivity of the src gene products of four Rous sarcoma virus mutants. J. Virol. 60:858–867.
  • O’Brien, T. P., G. P. Yang, L. Sanders, and L. F. Lau. 1990. Expression of CYR-61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10:3569–3577.
  • Ozaki, T., and S. Sakiyama. 1993. Molecular cloning and characterization of a cDNA showing negative regulation in v-src -transformed 3Y1 rat fibroblasts. Proc. Natl. Acad. Sci. USA 90:2593–2597.
  • Perbal, B.. 1994. Caractérisation et expression du proto-oncogene nov humain dans les tumeurs de Wilms. Bull. Cancer 81:957–961.
  • Perbal, B.. 1994. Contribution of MAV-1 induced chicken nephroblastoma to the study of genes involved in human Wilms’ tumor development. Crit. Rev. Oncogenesis 5:589–613.
  • Peterson, J. E., T. Jelinek, M. Kaleko, K. Siddle, and M. Weber. 1994. Phosphorylation and activation of the IGF-1 receptor in src transformed cells. J. Biol. Chem. 269:27315–27321.
  • Pierani, A., C. Pouponnot, and G. Calothy. 1993. Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src -responsive unit. Mol. Cell. Biol. 13:3401–3414.
  • Qureshi, S. A., X. Cao, V. P. Sukhatme, and D. A. Foster. 1991. v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements. J. Biol. Chem. 266:10802–10806.
  • Ryseck, R.-P., H. MacDonald-Bravo, M.-G. Mattei, and R. Bravo. 1991. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 2:225–233.
  • Schaller, M. D., C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds, and J. T. Parsons. 1992. pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89:5192–5196.
  • Scholz, G., M.-P. Felder, and H. Hanafusa. 1995. Activation of YRP kinase by v-Src and protein kinase C mediated signal transduction pathways. Proc. Natl. Acad. Sci. USA 92:2592–2596.
  • Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
  • Simmons, D. L., D. B. Levy, Y. Yannoni, and R. L. Erikson. 1989. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. USA 86:1178–1182.
  • Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702.
  • Spangler, R., C. Joseph, S. A. Qureshi, K. L. Berg, and D. A. Foster. 1989. Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. Proc. Natl. Acad. Sci. USA 86:7017–7021.
  • Stoeckle, M. Y., and H. Hanafusa. 1989. Processing of 9E3 mRNA and regulation of its stability in normal and Rous sarcoma virus-transformed cells. Mol. Cell. Biol. 9:4738–4745.
  • Sugano, S., M. Y. Stoeckle, and H. Hanafusa. 1987. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell 49:321–328.
  • Taylor, S. J., and D. Shalloway. 1993. The cell cycle and c-Src. Curr. Opin. Genet. Dev. 3:26–34.
  • Unkeless, J., K. Dano, G. M. Kellerman, and E. Reich. 1974. Fibrinolysis associated with oncogenic transformation: partial purification and characterization of the cell factor, a plasminogen activator. J. Biol. Chem. 249: 4295–4305.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.